Novartis AG
NOTA.STU
| Exchange: | STU |
| Currency | Euro |
| ISIN: | US66987V1098 |
| LEI: | 5493007HIVTX6SY6XD66 |
| Primary Ticker: | NVSEF.US |
| Fiscal Year End: | December |
| Updated On: | 2024-11-03 |
Highlights
| Market Capitalization: | 160075456947 |
| Market Capitalization Mln: | 160075.45 |
| PEG Ratio: | 3.25 |
| Dividend Yield: | 0.04 |
| Most Recent Quarter: | 2024-06-30 |
| Gross Profit TTM: | 33177000000 |
Valuation
| Forward PE: | 13.35 |
| Price Sales TTM: | 4.46 |
| Price Book MRQ: | 5.01 |
| Enterprise Value: | 219765383894 |
| Enterprise Value Revenue: | 4.78 |
| Enterprise Value Ebitda: | 12.13 |
Technicals
| 52 Week High: | 109 |
| 52 Week Low: | 82.53 |
| 50 Day MA: | 104.68 |
| 200 Day MA: | 97.58 |
Splits & Dividends
| Forward Annual Dividend Yield: | 0.04 |
Earnings
| Report Date: | 2025-07-16 |
| Date: | 2025-06-30 |
| Before After Market: | Before Market |
| Currency: | USD |
| Report Date: | 2025-04-21 |
| Date: | 2025-03-31 |
| Before After Market: | Before Market |
| Currency: | USD |
| Report Date: | 2025-01-31 |
| Date: | 2024-12-31 |
| Before After Market: | Before Market |
| Currency: | USD |
| Report Date: | 2024-10-29 |
| Date: | 2024-09-30 |
| Before After Market: | Before Market |
| Currency: | USD |
| Date: | 2024-09-30 |